Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 3/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.37 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7656122 | 0.89 | HRH1 (0.43) | ADRA1AHRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7656937 | 0.84 | HRH1 (0.45) | HRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7659345 | 0.81 | HRH1 (0.44) | ADRA1AHRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7657286 | 0.77 | HRH1 (0.51) | ADRA1AHRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7675326 | 0.74 | HRH1 (0.47) | ADRA1AHRH1HRH3SIGMAR1ADRA1D | |
| SCHEMBL7657825 | 0.73 | CCR2 (0.50) | ADRA1AHRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7660411 | 0.73 | HRH1 (0.53) | ADRA1AHRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7681283 | 0.68 | HRH1 (0.57) | ADRA1AHRH1HRH3SIGMAR1CNR1 | |
| SCHEMBL7652320 | 0.68 | HRH1 (0.54) | ADRA1AHRH1HRH3SIGMAR1ADRA1D | |
| SCHEMBL7675906 | 0.68 | HRH1 (0.54) | ADRA1AHRH1HRH3SIGMAR1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436962-B1 | ALPHA 1A ADRENERGIC RECEPTOR ANTAGONISTS; RELIEF FROM BENIGN PROSTATIC HYPERPLASIA BY LESS HINDERED URINE FLOW BY RELAXING SMOOTH MUSCLE TISSUE; WITH A TESTOSTERONE 5-ALPHA REDUCTASE INHIBITOR, FINASTERIDE; ACUTE AND CHRONIC RELIEF | MERCK & CO., INC. | 2002-08-20 | — | — | US | disclosed |